Skip To Main Content
Kenneth A. Katz on Muck Rack

Kenneth A. Katz

San Francisco
As seen in: The Washington Post, Wiley Online Library, JAMA (The Journal of the American Medical Association), JAMA Dermatology, The New England Journal of Medicine, The Sacramento Bee, STAT, Genetic Literacy Project, Journal of The American Academy of Dermatology (JAAD), Commercial Property Executive and
Medicine, Dermatology, LGBTQ Health, Empowerment, Diversity, Respect, Pronouns he, him, his. AIDS Life/Cycle 2022 donation link below 🙏
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kenneth A.

Contact Kenneth A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention

|
By Muhammad Junejo, Julia L. Marcus, Kenneth A. Katz
| JAMA (The Journal of the American Medical Association) Verified
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention The use of medicines to prevent sexually transmitted infection (STI) acquisition has a long history. Although some biomedical prevention efforts were successful, the emergence of resistance in Neisseria gonorrhoeae to numerous antibiotics during the 20th century dampened enthusiasm for these approaches.1 Biomedical STI prevention is back.
Open in Who Shared Issue with article?

Resistant Trichophyton indotineae Dermatophytosis-An Emerging Pandemic, Now in the US

|
By Kenneth A. Katz, Avrom S. Caplan, Gabrielle Todd
| JAMA (The Journal of the American Medical Association) Verified
Resistant Trichophyton indotineae Dermatophytosis—An Emerging Pandemic, Now in the US Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae Avrom S. Caplan, MD; Gabrielle C. Todd, PhD; YanChun Zhu, MS; Michelle Sikora, BS; Christine C. Akoh, MD, PhD; Jeannette Jakus, MD, MBA; Shari R. Lipner, MD, PhD; Kayla Babbush Graber, MD; Karen P. Acker, MD; Ayana E. Morales, MD; Rebecca M. Marrero Rolón, MD; Lars F.
Open in Who Shared Issue with article?

Home Narrowband UV-B Treatment for Psoriasis

|
By Kenneth A. Katz, Douglas Stram
| JAMA (The Journal of the American Medical Association) Verified
Although home narrowband UV-B (NBUVB) treatment for psoriasis is cost-effective,1,2 with high patient satisfaction and adherence,3 insurance plans have historically not covered it.4 In 2015, Kaiser Permanente Northern California (KPNC) began covering home NBUVB. We describe and identify patient characteristics associated with use of in-office NBUVB or systemic therapy following home NBUVB machine receipt.
Open in Who Shared Issue with article?
See all 23 licensed articles (24 Total)